Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002231:Carbimazole / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000188:drug therapy*; D007037:Hypothyroidism / Q000139:chemically induced; D007455:Iodine / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D013961:Thyroid Gland / Q000276:immunology; D013965:Thyroidectomy
D000906:Antibodies; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D008713:Methimazole; D011441:Propylthiouracil; D002231:Carbimazole; D007455:Iodine